TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of successful sheath insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Minimal residual disease negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative intravenous morphine consumption at 24 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACQ-5 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional connectivity (FC) between DMN and VAN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: children's food responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional overeating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: desire to drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall quality of life (QoL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of chronic radiation rectal injury
Endpoint domain: Adverse events/effects
Primary endpoint: VF deterioration risk
Endpoint domain: Mortality/survival
Primary endpoint: Vaginal delivery success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adverse outcome rates
Endpoint domain: Adverse events/effects
Primary endpoint: speed of processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction in severe exacerbations rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in asthma control and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease in THI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorption rate of fenofibric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax values of FS1 and FS2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Costs of grade 3/4 adverse events management
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ventilation increase during normobaric hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ILS flight performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effects during follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: frequent headaches at 30-day follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of analgesics
Endpoint domain: Resource use
Primary endpoint: clinical outcomes (VAS, AOFAS, satisfaction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS part II scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants with anxiety (HADS‐A ≥ 8)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean seroma formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean latencies of wave III&V of ABR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean inter wave latencies I‐III, I‐V& III‐V of ABR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Good-to-excellent clearance of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biceps Brachii Muscle Cross-Sectional Area (CSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Biceps Brachii Muscle Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: reduction of the cumulative lesional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: severity of the clinical score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decrease in the number of relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in signs and symptoms of VV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palliative care literacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-management
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Burnout likelihood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Social isolation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Job satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pulmonary functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 24-h ambulatory systolic blood pressure (sBP) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-h ambulatory diastolic blood pressure (dBP) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinic systolic blood pressure (sBP) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Muscle activation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥50% reduction of severe or moderate pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: anxiety modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Functioning Score of PedsQL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Communication level
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: expanded Apgar score at 5 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Live birth rate after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Clinical pregnancy rate after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Serum testosterone levels returning to normal values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Erections allowing intercourse without medical assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: fat-free mass (FFM) gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight-for-height z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise Performance (EP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in urinary tract infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in biochemical biomarkers (%HbA1C, hemoglobin, hematocrit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: presence of diabetic retinopathy (DR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year rate of induration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 2-year cumulative survival rates of restorations
Endpoint domain: Mortality/survival
Primary endpoint: reduction of periodontal pocket depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Left ventricular developed pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mini Mental State Examination (MMSE) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Montreal Cognitive Assessment (MoCA) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Able to function normally
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Satisfaction with study medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Migraine improvement on Patient Global Impression of Change scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: post-operative tenderness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children’s Depression Inventory (CDI‐S) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SCARED scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pediatric Quality of Life Inventory (PedsQL 4.0) score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: migraine-related functional disability freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hearing threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mandibular opening without pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with greater than 50% improvement in chewing pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K10 point decrease
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hoarseness incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Haemodynamic variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stigma as an obstacle to treatment and recovery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete closing of the biopsy-punch wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Gene upregulation in extracellular matrix molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: reporting of dropouts and withdrawals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: inclusion of active comparator
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: reporting of patient reported outcome measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of VAP development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of oropharyngeal colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: EARS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: days exercised in the past week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: RFD score for medical readiness for discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA response at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stabilized bone disease at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: responses in soft tissue lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔIBL (change in implant bone level)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Geometric mean ratio (GMR) for AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for oPac+E over IVP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discrimination of diabetes risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline 2-hour glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine albumin: creatinine ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of bilirubin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of afatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: timely care from qualified provider
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Combat non-response bias variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Military sexual trauma non-response bias variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mother-child interaction
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: plasma ketone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LIMA blood flow post papaverine application
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: VAS value difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BAI (Beck Anxiety Inventory)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HDRS (Hamilton Depression Rating Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Receipt of evidence-based cancer care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of monitoring visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of blood tests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of ultrasounds
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: All-cause mortality and HF admissions
Endpoint domain: Mortality/survival
Primary endpoint: Enrollment yield
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Brunnstrom stage improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6MWT score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for mechanical ventilation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Correlation between BMD and TBS Hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-test knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: post-test practice scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: trait appearance‐ideal internalization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: weight and shape concerns
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity of GA-VIBE MRI to detect suture closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of GA-VIBE MRI to detect suture closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clarity of imaging regions of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of discharge of lochia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction after PRGF-gel treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in fine lines and wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality-of-life dimension of joint damage perception
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: perceived functional abilities (lying/sitting/kneeling/standing)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: perceived functional abilities (complex lower extremities activities)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: maximum forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: arithmetic means of the force progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: standard deviations of the force progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: parental life span
Endpoint domain: Mortality/survival
Primary endpoint: health span
Endpoint domain: Mortality/survival
Primary endpoint: Saliva microbiota diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA-UE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sPGA(0,1) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Association of plasma PCSK9 with small HDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between plasma levels of PCSK9 and apolipoprotein-C3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extension lag of the DIP joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crawford criteria outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to disposition decision
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Laboratory turnaround time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: 10m Sprint Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30m Sprint Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in symptoms of MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PRTEE scores at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of successful treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intrapartum fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: histologic chorioamnionitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Seropositivity for neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CT utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incident elevated depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity for SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity for SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy for SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference of CPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 2 or worse RID
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean RIDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Symptom indexes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Right colon BS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right colon diminutive ADR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: EMPWR program completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pain self-efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mtDNA levels in luteal granulosa cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to full compaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to recurrent biliary obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stent dysfunction rate
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained ROSC
Endpoint domain: Mortality/survival
Primary endpoint: Cerebral performance category scores less than or equal to 2
Endpoint domain: Mortality/survival
Primary endpoint: Mean time to first successful endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: First-pass success rate for left selective intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Morbidity events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PR uptake within 28 days of hospital discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in trauma-related outcomes (SPRINT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in trauma-related outcomes (CPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes